Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AUDITORS’ ORATORY: how notified bodies cope with unannounced audit pressures

This article was originally published in Clinica

Executive Summary

In this second instalment of Auditor’s Oratory, where notified bodies share their experience and advice on coping with the evolving EU medtech regulatory climate, Paul Sim* of BSI explains how unannounced audits are changing the job of notified bodies. He also discusses how notified bodies, manufacturers and suppliers are being challenged, with all parties having to adapt and conquer a learning curve. The hope is that communication will improve and that the requirements will be fine-tuned to the advantage of all players.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT102415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel